| Am J Pathol. 1980 March; 98(3): 857–860. | PMCID: PMC1903511 |
Animal model of human disease: leukemic lymphoma. R. G. Olsen, L. E. Mathes, L. C. Hebebrand, E. A. Hoover, and W. S. Nichols Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (347K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Perryman, LE; Hoover, EA; Yohn, DS. Immunologic reactivity of the cat: immunosuppression in experimental feline leukemia. J Natl Cancer Inst. 1972 Nov;49(5):1357–1365. [PubMed]
- Anderson, LJ; Jarrett, WF; Jarrett, O; Laird, HM. Feline leukemia-virus infection of kittens: mortality associated with atrophy of the thymus and lymphoid depletion. J Natl Cancer Inst. 1971 Oct;47(4):807–817. [PubMed]
- Cockerell, GL; Hoover, EA; Krakowka, S; Olsen, RG; Yohn, DS. Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat. J Natl Cancer Inst. 1976 Nov;57(5):1095–1099. [PubMed]
- Dunlap, JE; Nichols, WS; Hebebrand, LC; Mathes, LE; Olsen, RG. Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines. Cancer Res. 1979 Mar;39(3):956–958. [PubMed]
- Hoover, EA; Krakowka, S; Cockerell, GL; Mathes, LE; Olsen, RG. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma. Am J Vet Res. 1978 Jun;39(6):993–995. [PubMed]
- Olsen, RG; Hoover, EA; Schaller, JP; Mathes, LE; Wolff, LH. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus. Cancer Res. 1977 Jul;37(7 Pt 1):2082–2085. [PubMed]
- Hebebrand, LC; Mathes, LE; Olsen, RG. Inhibition of concanavalin A stimulation of feline lymphocytes by inactivated feline leukemia virus. Cancer Res. 1977 Dec;37(12):4532–4533. [PubMed]
- Mathes, LE; Olsen, RG; Hebebrand, LC; Hoover, EA; Schaller, JP. Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein. Nature. 1978 Aug 17;274(5672):687–689. [PubMed]
- Mathes, LE; Olsen, RG; Hebebrand, LC; Hoover, EA; Schaller, JP; Adams, PW; Nichols, WS. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res. 1979 Mar;39(3):950–955. [PubMed]
- Faguet, GB. Quantitation of immunocompetence in Hodgkin's disease. J Clin Invest. 1975 Oct;56(4):951–957. [PubMed]
- Bobrove, AM; Fuks, Z; Strober, S; Kaplan, HS. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer. 1975 Jul;36(1):169–179. [PubMed]
- Ben-bassat, H. Changes in the surface membrane of lymphocytes from patients with chronic lymphocytic leukemia and malignant lymphomas. Isr J Med Sci. 1977 Aug;13(8):758–766. [PubMed]
- Hebebrand, LC; Olsen, RG; Mathes, LE; Nichols, WS. Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus. Cancer Res. 1979 Feb;39(2 Pt 1):443–447. [PubMed]
- Twomey, JJ; Laughter, AH; Farrow, S; Douglass, CC. Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest. 1975 Aug;56(2):467–475. [PubMed]
- Jacquemin, PC; Saxinger, C; Gallo, RC. Surface antibodies of human myelogenous leukaemia leukocytes reactive with specific type-C viral reverse transcriptases. Nature. 1978 Nov 16;276(5685):230–236. [PubMed]
|
